An FDA advisory committee recently voted to include BPC-157, a popular peptide, on a list for drug compounding. Drug compounding involves creating personalized medications by mixing ingredients to meet specific patient needs. BPC-157 is known for its potential healing properties and is often used by athletes and others seeking to improve recovery and performance. The decision to add it to the compounding list means it could become more widely available and regulated, ensuring safer use for those who need it. This move highlights the ongoing efforts to balance innovation in medicine with safety and accessibility for patients.
QUESTION: How might the increased availability and regulation of BPC-157 impact the way athletes and others approach recovery and performance enhancement?
FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list
